Document Detail

Successful use of tissue plasminogen activator in catheter-related intracardiac thrombus of a premature infant.
MedLine Citation:
PMID:  12660914     Owner:  NLM     Status:  MEDLINE    
The incidence of clinically apparent neonatal thrombosis is about 0.1 to 0.2% in the neonatal intensive care unit (NICU). The optimal treatment modalities for neonates with thromboses are not known. We report on our experience with recombinant tissue type plasminogen activator (rt-PA) in a premature infant with an intracardiac thrombus.
M J Torres-Valdivieso; J Cobas; C Barrio; C Muñoz; M Pascual; C Orbea; E Rodriguez; F Gutiérrez
Related Documents :
19614884 - An ecological model for premature infant feeding.
21083904 - The first three years of screening for medium chain acyl-coa dehydrogenase deficiency (...
7596684 - Frequency and cytokine phenotype of blood t cells from premature infants responding to ...
10148854 - The clinical utility of serum creatinine measurement vs calculated glomerular filtratio...
20347414 - Associations of early life risk factors with infant sleep duration.
19912084 - Screening for hepatitis c virus infection in methadone-maintained mothers and their inf...
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  American journal of perinatology     Volume:  20     ISSN:  0735-1631     ISO Abbreviation:  Am J Perinatol     Publication Date:  2003 Feb 
Date Detail:
Created Date:  2003-03-27     Completed Date:  2003-07-07     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  8405212     Medline TA:  Am J Perinatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  91-6     Citation Subset:  IM    
Section of Perinatology, Hospital 12 de Octubre, Madrid, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Catheterization, Central Venous / adverse effects*
Diseases in Twins
Dose-Response Relationship, Drug
Heart Diseases / drug therapy*,  etiology,  ultrasonography
Infant, Newborn
Infant, Premature, Diseases / drug therapy*,  etiology,  ultrasonography
Plasminogen Activators / administration & dosage*
Thrombosis / drug therapy*,  etiology,  ultrasonography
Time Factors
Tissue Plasminogen Activator / administration & dosage*
Treatment Outcome
Reg. No./Substance:
EC 3.4.21.-/Plasminogen Activators; EC Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A new computerized analysis to precisely evaluate heart rate variability during the nonstress test.
Next Document:  Role of antioxidant nutrients and lipid peroxidation in premature infants with respiratory distress ...